DMD
DMD Duchenne muscular dystrophy is the most common muscular dystrophy, affecting approximately 1 in every 3,500 newborn males. It is caused by a fault in a gene called the dystrophin or the DMD gene. A fault in this gene stops the body making a protein called dystrophin, which is important in helping build muscle fibres, and its absence results in muscle weakness that gets worse over time because muscle cells break down and are lost gradually.
Duchenne results in progressive loss of strength and is caused by a mutation in the gene that encodes dystrophin. The progressive muscle weakness leads to serious medical problems, particularly issues related to the heart and lungs. Typically, boys with Duchenne lose their ability to walk between the ages of ten and fourteen. By their late teens, they lose the strength in their upper bodies, including the ability to move their arms.
The disease also affects the heart and breathing muscles, so around this time they also usually need help with breathing at night. Over time, their respiratory systems weaken, and they require constant support. Young men with Duchenne do have a shorter life expectancy but advances in management of the condition have increased life span significantly and enabled young men to lead much more independent lives than was previously possible.
The good news is that the novel therapies are emerging and there are some treatments to improve and avoid complications for DMD patients and the earlier you follow up with the specialist the better it gets and dramatically improves the quality of life and life expectancy of individuals with DMD, enabling them to lead fulfilling, independent lives into adulthood.
OFFICE HOURS
Daily
5:00 – 12:00 pm
01123734572
Expert Egyptian AMD
Vision
Together as Muscular Dystrophy patients, we established the Egyptian Association of Muscular Dystrophy to be a reference and shelter for each & every muscular dystrophy patient striving together to reach new therapies and the care they deserve.
Mission
At EAMD we are committed to help each MD patient to maintain a better Quality of life to reach their full potential, by offering them comprehensive tailored care.
Values
- Empathy: we can feel the suffering of muscular dystrophy community in Egypt.
- Leadership: we aim to be the reference and source of awareness for patients and their caregivers.
- Empowerment: we work hard to provide every MD patient with essential tools to live a powerful life.
Goals
- Expanding the association activities by extending arms across the whole country to make it easier for the patient to reach support wherever they are.
- To provide suitable employment opportunities that is not less than the minimum wage or appointment in accordance with the educational qualifications.
- Allocation of housing units within the provinces for those with special needs and the necessary amenities.
- Building a medical building on a global level to receive and treat cases of patients with muscular atrophy and the disabled.
- Work on the issuance and amendment of legislation for patients with muscular atrophy and disabled in accordance with the current circumstances.
Other Diseases
Becker muscular dystrophy (BMD) is a condition which causes weakness in the muscles, affects mainly male children, like all muscular dystrophy diseases.
CMD (congenital muscular dystrophy) is in fact not one single condition but a number of different inherited neuromuscular conditions that are grouped under the label “congenital”
DMD Duchenne muscular dystrophy is the most common muscular dystrophy, affecting approximately 1 in every 3,500 newborn males
FSHD Facioscapulohumeral muscular dystrophy (FSHD) is the third most common type of muscular dystrophy worldwide. The prevalence of the disease is estimated at about one in 20,000.
Appointment Booking
Our Team are waiting for your requests and we will answer asap.